Quantum Biopharma Class B Subordinate Voting Shares
QNTM
17 hedge funds and large institutions have $383K invested in Quantum Biopharma Class B Subordinate Voting Shares in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 5 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
33% more call options, than puts
Call options by funds: $77K | Put options by funds: $58K
4% more capital invested
Capital invested by funds: $369K → $383K (+$13.9K)
0% more ownership
Funds ownership: 0.02% → 0.02% (+0%)
11% less funds holding
Funds holding: 19 → 17 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$126K |
| 2 |
Renaissance Technologies
New York
|
+$24.2K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$19K |
| 4 |
Creative Planning
Overland Park,
Kansas
|
+$12.7K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$6.24K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$35K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$25.4K |
| 3 |
Jane Street
New York
|
-$21K |
| 4 |
Wolverine Trading
Chicago,
Illinois
|
-$18.3K |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$15K |
QNTM Hedge Fund Activity: Q2 2022 in Review
17 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Quantum Biopharma Class B Subordinate Voting Shares (QNTM) for Q2 2022, worth a combined $383K — up 3.8% from $369K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of QNTM and 3 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 6 added.
The largest buyer was AdvisorShares Investments, adding an estimated $126K. The largest seller was Virtu Financial, exiting entirely with an estimated $35K sold.
- 17 institutional investors held Quantum Biopharma Class B Subordinate Voting Shares (QNTM) as of Q2 2022, down from 19 in Q1 2022.
- Funds reported $383K of Quantum Biopharma Class B Subordinate Voting Shares stock for Q2 2022, up 3.8% quarter-over-quarter.
- 3 funds opened new Quantum Biopharma Class B Subordinate Voting Shares positions in Q2 2022 and 5 closed out, a net change of -2 holders.
- The largest Quantum Biopharma Class B Subordinate Voting Shares buyer in Q2 2022 was AdvisorShares Investments, an estimated $126K added.
- The largest Quantum Biopharma Class B Subordinate Voting Shares seller in Q2 2022 was Virtu Financial, an estimated $35K sold.
Based on aggregated 13F filings for Q2 2022.